Update on Patient Enrollment for Pivotal Study of NGAL in

November 3, 2021Announcement no. 19 Update on Patient Enrollment for Pivotal Study of NGAL in Pediatrics COVID-19 has continued to impact hospital...

Related Keywords

Tim Eriksen ,Bioportoas Bioporto ,Drug Administration ,Patient Enrollment ,Pivotal Study ,Christopher Bird ,Chief Medical Officer ,Breakthrough Designation ,Interim Report ,Second Quarter ,Copenhagen Stock Exchange Biopor ,Bioportoa S ,